0615-7703 : Ziprasidone Hydrochloride 80 mg Oral Capsule


NDC0615-7703
Labeler: Ncs Healthcare of Ky, Inc Dba Vangard Labs
Product Type: Human Prescription Drug
Drug Name:  Ziprasidone Hydrochloride
Dosage Form: Oral Capsule
Application #: ANDA077565
Rev. Date: 


Appearance:


Markings: RDY;259
Shapes:  Capsule
Colors:  Blue
Size (mm): 18
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

RDY 259: (55111-259) Ziprasidone Hydrochloride 80 mg Oral Capsule by Ncs Healthcare of Ky, Inc Dba Vangard Labs
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0615-7703-39: 30 CAPSULE IN 1 BLISTER PACK (0615‑7703‑39)

Active Ingredients:

  • Ziprasidone Hydrochloride

Dosage Strength:

  • 80 mg

Inactive Ingredients:

  • Anhydrous Lactose
  • Magnesium Stearate
  • Polysorbate 80
  • Povidone K30
  • Starch, Corn
  • Silicon Dioxide
  • Fd&c Blue No. 1
  • Fd&c Red No. 3
  • Gelatin
  • Ferric Oxide Red
  • Titanium Dioxide
  • Ferrosoferric Oxide
  • Butyl Alcohol
  • Alcohol
  • Isopropyl Alcohol
  • Potassium Hydroxide
  • Propylene Glycol
  • Shellac
  • Ammonia

Pharmaceutical Classes:

  • Atypical Antipsychotic [EPC]

Related Products:

Based on records with the same trade name.
  • 0378-7350 Ziprasidone Hydrochloride 20 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-7351 Ziprasidone Hydrochloride 40 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-7352 Ziprasidone Hydrochloride 60 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-7353 Ziprasidone Hydrochloride 80 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0781-2164 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 20 mg Oral Capsule by Sandoz Inc
  • 0781-2166 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 40 mg Oral Capsule by Sandoz Inc
  • 0781-2167 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 60 mg Oral Capsule by Sandoz Inc
  • 0781-2168 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 80 mg Oral Capsule by Sandoz Inc
  • 0904-6269 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 20 mg Oral Capsule by Major Pharmaceuticals
  • 0904-6270 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 40 mg Oral Capsule by Major Pharmaceuticals
  • 0904-6271 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 60 mg Oral Capsule by Major Pharmaceuticals
  • 0904-6272 Ziprasidone (As Ziprasidone Hydrochloride Monohydrate) 80 mg Oral Capsule by Major Pharmaceuticals
  • 16714-835 Ziprasidone Hydrochloride 20 mg Oral Capsule by Northstar Rx LLC
  • 16714-836 Ziprasidone Hydrochloride 40 mg Oral Capsule by Northstar Rx LLC
  • 16714-837 Ziprasidone Hydrochloride 60 mg Oral Capsule by Northstar Rx LLC
  • 16714-838 Ziprasidone Hydrochloride 80 mg Oral Capsule by Northstar Rx LLC
  • 33342-144 Ziprasidone Hydrochloride 20 mg Oral Capsule by Macleods Pharmaceuticals Limited
  • 33342-145 Ziprasidone Hydrochloride 40 mg Oral Capsule by Macleods Pharmaceuticals Limited
  • 33342-146 Ziprasidone Hydrochloride 60 mg Oral Capsule by Macleods Pharmaceuticals Limited
  • 33342-147 Ziprasidone Hydrochloride 80 mg Oral Capsule by Macleods Pharmaceuticals Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0615-7703 QR Code

< Prev: 0615-7699Next: 0615-7704 >

Related Discussions:

ziprasidone 40 mg
What is ziprasidone 40 mg. Perscriped for? ## Hello, Missa! How are you? This is an atypical antipsychotic that's us... 1 reply
Ziprasidone
Not sure what this drug is used for??...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.